113.52

5.31% -5.7065

Repligen Corp (RGEN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RGEN Giù? Forum Previsione

Precedente Chiudi:

$119.23

Aprire:

$117.25

Volume 24 ore:

571.81K

Relative Volume:

0.80

Capitalizzazione di mercato:

$6.40B

Reddito:

$633.51M

Utile/perdita netta:

$-8.10M

Rapporto P/E:

-366.20

EPS:

-0.31

Flusso di cassa netto:

$131.26M

1 W Prestazione:

-9.70%

1M Prestazione:

-14.87%

6M Prestazione:

-0.56%

1 anno Prestazione:

-22.33%

Intervallo 1D:

$112.47

$118.76

Intervallo di 1 settimana:

$112.47

$129.00

Portata 52W:

$102.97

$175.77

Repligen Corp Stock (RGEN) Company Profile

Nome

Repligen Corp

Settore

Healthcare (1115)

Industria

Medical Instruments & Supplies (58)

Telefono

(781) 449-9560

Indirizzo

41 SEYON STREET, WALTHAM, MA

Dipendente

2,000

Cinguettio

@repligen

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, ALC, RMD, MDLN

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RGEN Repligen Corp	113.69	6.72B	633.51M	-8.10M	131.26M	-0.31
ISRG Intuitive Surgical Inc	476.76	175.03B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	159.25	46.42B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	78.78	39.37B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	233.50	34.98B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	41.47	34.41B	28.43B	1.16B	1.26B	1.4457

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-01	Iniziato	HSBC Securities	Buy
2025-09-22	Aggiornamento	Evercore ISI	In-line → Outperform
2025-07-22	Ripresa	Stephens	Overweight
2025-06-24	Iniziato	Barclays	Overweight
2025-04-29	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-03-18	Iniziato	Evercore ISI	In-line
2025-02-10	Iniziato	TD Cowen	Buy
2024-12-17	Iniziato	Canaccord Genuity	Hold
2024-11-14	Iniziato	Wolfe Research	Peer Perform
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-26	Aggiornamento	Deutsche Bank	Hold → Buy
2024-06-18	Iniziato	Guggenheim	Neutral
2023-12-04	Downgrade	The Benchmark Company	Buy → Hold
2023-07-20	Iniziato	Wells Fargo	Overweight
2023-07-05	Ripresa	JP Morgan	Overweight
2023-03-28	Iniziato	The Benchmark Company	Buy
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-12-07	Iniziato	RBC Capital Mkts	Sector Perform
2022-07-20	Iniziato	UBS	Buy
2021-10-14	Iniziato	Exane BNP Paribas	Outperform
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-30	Reiterato	H.C. Wainwright	Buy
2020-05-07	Reiterato	H.C. Wainwright	Buy
2020-03-23	Reiterato	H.C. Wainwright	Buy
2019-11-15	Iniziato	Stifel	Buy
2019-11-01	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-10-15	Iniziato	SVB Leerink	Outperform
2019-08-28	Reiterato	First Analysis Sec	Outperform
2019-08-23	Ripresa	Stephens	Overweight
2019-07-22	Aggiornamento	H.C. Wainwright	Neutral → Buy
2018-12-17	Aggiornamento	CL King	Neutral → Buy
2018-11-12	Downgrade	CL King	Buy → Neutral
2018-09-26	Iniziato	H.C. Wainwright	Neutral
2017-12-08	Iniziato	Citigroup	Buy
2017-12-05	Iniziato	JP Morgan	Overweight
2017-11-13	Iniziato	CL King	Buy
2017-10-02	Aggiornamento	First Analysis Sec	Equal-Weight → Overweight
2017-07-21	Iniziato	William Blair	Outperform
2017-02-13	Aggiornamento	Piper Jaffray	Neutral → Overweight

Mostra tutto

Repligen Corp Borsa (RGEN) Ultime notizie

Mar 11, 2026

Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 11, 2026

Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat

Mar 11, 2026

Mar 10, 2026

Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com

Mar 10, 2026

Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance

Mar 08, 2026

Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance

Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st

Mar 08, 2026

Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 08, 2026

Mar 06, 2026

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 06, 2026

Mar 05, 2026

NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat

Mar 04, 2026

Mar 03, 2026

Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan

Mar 03, 2026

Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan

Mar 03, 2026

Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan

Mar 03, 2026

Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan

Mar 03, 2026

Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan

Mar 03, 2026

Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan

Mar 03, 2026

Mar 02, 2026

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews

Mar 02, 2026

Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat

Mar 02, 2026

Mar 01, 2026

Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat

Mar 01, 2026

Feb 28, 2026

Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat

Feb 28, 2026

Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Feb 28, 2026

Feb 27, 2026

Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance

Feb 27, 2026